Comparative clinical study of Aragwadha churna and Guduchi churna in Vatarakta

Effect of Aragwadha churna as compared to Guduchi churna in management of Vatarakta (Gout):A Randomized controlled trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/075813

Enrollment

Registered

2024-10-24

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M100- Idiopathic gout

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient with sign and symptoms of Vatarakta as mentioned in Samhitas. Patient age group between 30-60yrs. Patients selected irrespective of age, Sex, socio economic status. Patient with hyperuricemia 7-10 mg/dl. Newly diagnosed patients.

Exclusion criteria

Exclusion criteria: Pregnant women and lactating mothers. Patients with sign and symptoms of Amavata and Sandhigatavata. Patient having sign and symptoms of vatarakta more than 1 year.(chronic gout). Patient with uric acid level above 10 mg/

Design outcomes

Primary

Measure	Time frame
To compare the effect of Aragwadha churna and Guduchi churna in the management of vatarakta (gout)to be assessed by relief of symptoms To compare the effect of Aragwadha churna and Guduchi churna in the management of vatrakta(gout) to be assessed by sr.uric acid levelTimepoint: Follow up will be taken every 7th day for 28 days	—

Secondary

Measure	Time frame
To compare the effect of Aragwadha churna and Guduchi churna in the management of vatrakta(gout) to be assessed by sr.uric acid levelTimepoint: At the end of 28 days	—

Countries

India

Contacts

Public ContactVd Mrityunjay Sharma

Shri Ayurved Mahavidyalaya,Nagpur

mrityunjaysharma22@gmail.com9373103182

Outcome results